Navigation Links
Receptos Files Registration Statement for Proposed Initial Public Offering
Date:4/4/2013

SAN DIEGO, April 4, 2013 /PRNewswire/ -- Receptos, Inc., a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock.  All shares of the common stock to be sold in the offering will be offered by Receptos.  The number of shares to be offered and the price range for the offering have not yet been determined.

Credit Suisse Securities (USA) LLC, Leerink Swann LLC and BMO Capital Markets are acting as joint book-running managers for the offering.  Wedbush PacGrow Life Sciences is acting as a co-manager.  The offering will be made only by means of a prospectus.  When available, copies of the preliminary prospectus relating to and describing the terms of the offering may be obtained from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, Telephone: (800) 221-1037, Email: newyork.prospectus@credit-suisse.com; from Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, Telephone: (800) 808-7525, Email: syndicate@leerink.com; or from BMO Capital Markets, Attention: Equity Syndicate Department, 3 Times Square, New York, NY 10036, Telephone: (800) 414-3627, Email: bmoprospectus@bmo.com.

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective.  These securities may not be sold nor may offers to buy be accepted prior to the
'/>"/>

SOURCE Receptos, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
2. Receptos to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference
3. Graham Cooper Appointed Chief Financial Officer of Receptos
4. Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
5. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
6. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
7. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
8. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
9. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
10. Sunpeaks Ventures Files Defamation Lawsuit
11. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... SAN DIEGO , Oct. 22, 2014 ... II medical device received 510 (k) OTC clearance by ... the AVACEN 100 to be marketed over the Internet ... with arthritis; muscle spasms; and minor strains and sprains ... The AVACEN 100 (MSRP $2495) is a ...
(Date:10/22/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... company focused on the development of oral drug ... from its Phase IIa clinical trial of ORMD-0801, ... type 1 diabetes. The trial was conducted in ... U.S. Food and Drug Administration (FDA) Investigational New ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
(Date:10/22/2014)... Healthcare professionals who are looking ... at home or on-the-go via laptops, tablets or ... new, premium Seminar-on-Demand CE courses. The new courses ... 2,000 hours of CE course offerings, allowing ... With such a diverse library, there’s something for ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Although there are only ... time for many people who have trouble finding time within their ... to exercise for long periods of time to get in shape. ... goals while on the go. , Change Up Your Commute ... to work to add some exercise into your daily routine. If ...
(Date:10/22/2014)... PA (PRWEB) October 22, 2014 Richard ... as an industry leader with over 25 years experience. ... team leader in the areas related to EDI, B2B ... Carlson is an Editorial Advisory Board member for Pharmaceutical ... Educator. Blue Fin Group is a management and ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... earlier research involving hormone therapy , , WEDNESDAY, April ... therapy appear to have a 28 percent reduction in ... found. , But researchers don,t yet know why the ... women remains the same: Take hormone replacement therapy at ...
... young baseball playersROSEMONT, Ill., April 22 For generations, baseball ... for kids to get some exercise along with their first ... of Orthopaedic Surgeons ( http://www.aaos.org ) (AAOS) urges ... , ...
... celebritiesParis Hilton, Nicole Ritchie, Michelle Rodriguez and Lindsay Lohanyielded ... any public health context, according to a new report ... Public Health,s Center for Injury Research and Policy. Analyzing ... and the evening news broadcasts from ABC, NBC, CBS, ...
... heavier people produces more greenhouse gases, researchers say , , ... does more than protect your health. It also ... London School of Hygiene & Tropical Medicine say that ... gases, a lean population, such as in Vietnam, consumes ...
... Newly established CandleInTheWindow.org announces a $1,000 scholarship/award for ... pregnant women in need that the bearer of the symbol ... to get beyond the labels of Pro-life and Pro-choice and ... Everyneighborhood, USA there are hundreds of people right ...
... School of Medicine and the Moores UCSD Cancer Center have ... to be part of the first line of defense against ... found that when these cells, known as lymphocytes, make an ... likely to spread to the lungs. , They have ...
Cached Medicine News:Health News:HRT May Protect Women From Colon Cancer 2Health News:Swing That Bat Into Baseball Season, Injury Free 2Health News:Swing That Bat Into Baseball Season, Injury Free 3Health News:Media ignores health consequences of drinking and driving among young celebrities 2Health News:Staying Slim Is Good for the Environment 2Health News:$1000 Scholarship/Award for Best Poster/Ribbon Design That Encourages Needy Pregnant Women to Ask Bearers for Help 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2
... III Model 8042 increases therapy versatility ... to optimize sensing, pacing and cardiac ... offers unmatched insight through key heart ... efficiently track a patient's clinical status. ...
... OTI-Scan 3D is the ... system available today. This ... and A-scan system operates ... desktop or laptop computer ...
... is an extremely accurate digital A-scan system. ... noise probe and fast precise algorithm enables ... probe along the visual axis. The A5500 ... CRT monitor, built-in thermal printer, 5 different ...
... Accurate, efficient and easy to use. The ... variety of regressive, theoretical, and adaptive IOL ... the patient. Convenient design features improve your ... hands-free operation, audible tone to minimize corneal ...
Medicine Products: